New

Nasal Vaccines Market

2021

Nasal Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Flu Vaccines, COVID-19 Vaccines, and Others); Dosage Form (Adults, and Children); End Use (Hospitals, Clinics, and Others), and Geography

| Report Code: TIPRE00023215 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Nasal Vaccines Market 2028 By Type, Dosage Form, End Use, and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Nasal vaccines can be administered through the nasal cavity or nose by using an atomizer or syringe. Bacteria and viruses of various types cause infections of the nasal mucosa. Nasal vaccines may undoubtedly be a more viable vaccine delivery alternative, as vaccine formulations are better absorbed in the mucosal surface. Nasal vaccines protect the infection site and produce mucosal and systemic immune responses. Drug manufacturers are developing nasal vaccines, including live-attenuated pathogens, adjuvants, nanoparticles, mucoadhesives, virus-like particles, DNA vaccines, and lipid-based particulates. Because of the non-invasive nature, ease of administration, and high immunization potential, nasal vaccines are rapidly becoming more viable alternatives to other routes of vaccine administration.

MARKET SCOPE

The "Global Nasal Vaccines Market Analysis to 2028" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of the Nasal vaccines market with detailed market segmentation by type, dosage form, end use, and geography. The report provides key statistics on the market status of the leading Nasal vaccines market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on type, the global Nasal vaccines market is segmented into flu vaccines, covid-19 vaccines, others.
  •  On the basis of dosage form, the market is segmented into adults, children.
  •  On the basis of end use, the market is segmented into hospitals, clinics, others.

MARKET DYNAMICS
Drivers

  •   Rise in the incidences of nasal infections .
  •   Increase in patience compliance.
  •   Emergence of coronavirus pandemic.
  •   Growing research and development.

Restraints

  •   The restricted delivery and limited efficacy are the major restraining factor for this market.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The Nasal vaccines market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the Nasal vaccines market in these regions.

IMPACT OF COVID-19 ON NASAL VACCINES MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Nasal vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from Nasal vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for Nasal vaccines in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Nasal vaccines market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Sanofi
  •  AstraZeneca
  •  Abbott
  •  GlaxoSmithKline
  •  Serum Institute of India
  •  Bharat Biotech
  •  Antares Pharma
  •  INJEX Pharma GmbH
  •  BioDiem
  •  PharmaJet

The Insight Partner's dediNasal vaccinesed research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Nasal Vaccines Market - By Type
1.3.2 Nasal Vaccines Market - By Dosage Form
1.3.3 Nasal Vaccines Market - By End Use
1.3.4 Nasal Vaccines Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NASAL VACCINES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NASAL VACCINES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. NASAL VACCINES MARKET - GLOBAL MARKET ANALYSIS
6.1. NASAL VACCINES - GLOBAL MARKET OVERVIEW
6.2. NASAL VACCINES - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. NASAL VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. FLU VACCINES
7.3.1. Overview
7.3.2. Flu Vaccines Market Forecast and Analysis
7.4. COVID-19 VACCINES
7.4.1. Overview
7.4.2. COVID-19 Vaccines Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis
8. NASAL VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - DOSAGE FORM
8.1. OVERVIEW
8.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
8.3. ADULTS
8.3.1. Overview
8.3.2. Adults Market Forecast and Analysis
8.4. CHILDREN
8.4.1. Overview
8.4.2. Children Market Forecast and Analysis
9. NASAL VACCINES MARKET - REVENUE AND FORECASTS TO 2028 - END USE
9.1. OVERVIEW
9.2. END USE MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. NASAL VACCINES MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Nasal Vaccines Market Overview
10.1.2 North America Nasal Vaccines Market Forecasts and Analysis
10.1.3 North America Nasal Vaccines Market Forecasts and Analysis - By Type
10.1.4 North America Nasal Vaccines Market Forecasts and Analysis - By Dosage Form
10.1.5 North America Nasal Vaccines Market Forecasts and Analysis - By End Use
10.1.6 North America Nasal Vaccines Market Forecasts and Analysis - By Countries
10.1.6.1 United States Nasal Vaccines Market
10.1.6.1.1 United States Nasal Vaccines Market by Type
10.1.6.1.2 United States Nasal Vaccines Market by Dosage Form
10.1.6.1.3 United States Nasal Vaccines Market by End Use
10.1.6.2 Canada Nasal Vaccines Market
10.1.6.2.1 Canada Nasal Vaccines Market by Type
10.1.6.2.2 Canada Nasal Vaccines Market by Dosage Form
10.1.6.2.3 Canada Nasal Vaccines Market by End Use
10.1.6.3 Mexico Nasal Vaccines Market
10.1.6.3.1 Mexico Nasal Vaccines Market by Type
10.1.6.3.2 Mexico Nasal Vaccines Market by Dosage Form
10.1.6.3.3 Mexico Nasal Vaccines Market by End Use
10.2. EUROPE
10.2.1 Europe Nasal Vaccines Market Overview
10.2.2 Europe Nasal Vaccines Market Forecasts and Analysis
10.2.3 Europe Nasal Vaccines Market Forecasts and Analysis - By Type
10.2.4 Europe Nasal Vaccines Market Forecasts and Analysis - By Dosage Form
10.2.5 Europe Nasal Vaccines Market Forecasts and Analysis - By End Use
10.2.6 Europe Nasal Vaccines Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Nasal Vaccines Market
10.2.6.1.1 Germany Nasal Vaccines Market by Type
10.2.6.1.2 Germany Nasal Vaccines Market by Dosage Form
10.2.6.1.3 Germany Nasal Vaccines Market by End Use
10.2.6.2 France Nasal Vaccines Market
10.2.6.2.1 France Nasal Vaccines Market by Type
10.2.6.2.2 France Nasal Vaccines Market by Dosage Form
10.2.6.2.3 France Nasal Vaccines Market by End Use
10.2.6.3 Italy Nasal Vaccines Market
10.2.6.3.1 Italy Nasal Vaccines Market by Type
10.2.6.3.2 Italy Nasal Vaccines Market by Dosage Form
10.2.6.3.3 Italy Nasal Vaccines Market by End Use
10.2.6.4 Spain Nasal Vaccines Market
10.2.6.4.1 Spain Nasal Vaccines Market by Type
10.2.6.4.2 Spain Nasal Vaccines Market by Dosage Form
10.2.6.4.3 Spain Nasal Vaccines Market by End Use
10.2.6.5 United Kingdom Nasal Vaccines Market
10.2.6.5.1 United Kingdom Nasal Vaccines Market by Type
10.2.6.5.2 United Kingdom Nasal Vaccines Market by Dosage Form
10.2.6.5.3 United Kingdom Nasal Vaccines Market by End Use
10.2.6.6 Rest of Europe Nasal Vaccines Market
10.2.6.6.1 Rest of Europe Nasal Vaccines Market by Type
10.2.6.6.2 Rest of Europe Nasal Vaccines Market by Dosage Form
10.2.6.6.3 Rest of Europe Nasal Vaccines Market by End Use
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Nasal Vaccines Market Overview
10.3.2 Asia-Pacific Nasal Vaccines Market Forecasts and Analysis
10.3.3 Asia-Pacific Nasal Vaccines Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Nasal Vaccines Market Forecasts and Analysis - By Dosage Form
10.3.5 Asia-Pacific Nasal Vaccines Market Forecasts and Analysis - By End Use
10.3.6 Asia-Pacific Nasal Vaccines Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Nasal Vaccines Market
10.3.6.1.1 Australia Nasal Vaccines Market by Type
10.3.6.1.2 Australia Nasal Vaccines Market by Dosage Form
10.3.6.1.3 Australia Nasal Vaccines Market by End Use
10.3.6.2 China Nasal Vaccines Market
10.3.6.2.1 China Nasal Vaccines Market by Type
10.3.6.2.2 China Nasal Vaccines Market by Dosage Form
10.3.6.2.3 China Nasal Vaccines Market by End Use
10.3.6.3 India Nasal Vaccines Market
10.3.6.3.1 India Nasal Vaccines Market by Type
10.3.6.3.2 India Nasal Vaccines Market by Dosage Form
10.3.6.3.3 India Nasal Vaccines Market by End Use
10.3.6.4 Japan Nasal Vaccines Market
10.3.6.4.1 Japan Nasal Vaccines Market by Type
10.3.6.4.2 Japan Nasal Vaccines Market by Dosage Form
10.3.6.4.3 Japan Nasal Vaccines Market by End Use
10.3.6.5 South Korea Nasal Vaccines Market
10.3.6.5.1 South Korea Nasal Vaccines Market by Type
10.3.6.5.2 South Korea Nasal Vaccines Market by Dosage Form
10.3.6.5.3 South Korea Nasal Vaccines Market by End Use
10.3.6.6 Rest of Asia-Pacific Nasal Vaccines Market
10.3.6.6.1 Rest of Asia-Pacific Nasal Vaccines Market by Type
10.3.6.6.2 Rest of Asia-Pacific Nasal Vaccines Market by Dosage Form
10.3.6.6.3 Rest of Asia-Pacific Nasal Vaccines Market by End Use
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Nasal Vaccines Market Overview
10.4.2 Middle East and Africa Nasal Vaccines Market Forecasts and Analysis
10.4.3 Middle East and Africa Nasal Vaccines Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Nasal Vaccines Market Forecasts and Analysis - By Dosage Form
10.4.5 Middle East and Africa Nasal Vaccines Market Forecasts and Analysis - By End Use
10.4.6 Middle East and Africa Nasal Vaccines Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Nasal Vaccines Market
10.4.6.1.1 South Africa Nasal Vaccines Market by Type
10.4.6.1.2 South Africa Nasal Vaccines Market by Dosage Form
10.4.6.1.3 South Africa Nasal Vaccines Market by End Use
10.4.6.2 Saudi Arabia Nasal Vaccines Market
10.4.6.2.1 Saudi Arabia Nasal Vaccines Market by Type
10.4.6.2.2 Saudi Arabia Nasal Vaccines Market by Dosage Form
10.4.6.2.3 Saudi Arabia Nasal Vaccines Market by End Use
10.4.6.3 U.A.E Nasal Vaccines Market
10.4.6.3.1 U.A.E Nasal Vaccines Market by Type
10.4.6.3.2 U.A.E Nasal Vaccines Market by Dosage Form
10.4.6.3.3 U.A.E Nasal Vaccines Market by End Use
10.4.6.4 Rest of Middle East and Africa Nasal Vaccines Market
10.4.6.4.1 Rest of Middle East and Africa Nasal Vaccines Market by Type
10.4.6.4.2 Rest of Middle East and Africa Nasal Vaccines Market by Dosage Form
10.4.6.4.3 Rest of Middle East and Africa Nasal Vaccines Market by End Use
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Nasal Vaccines Market Overview
10.5.2 South and Central America Nasal Vaccines Market Forecasts and Analysis
10.5.3 South and Central America Nasal Vaccines Market Forecasts and Analysis - By Type
10.5.4 South and Central America Nasal Vaccines Market Forecasts and Analysis - By Dosage Form
10.5.5 South and Central America Nasal Vaccines Market Forecasts and Analysis - By End Use
10.5.6 South and Central America Nasal Vaccines Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Nasal Vaccines Market
10.5.6.1.1 Brazil Nasal Vaccines Market by Type
10.5.6.1.2 Brazil Nasal Vaccines Market by Dosage Form
10.5.6.1.3 Brazil Nasal Vaccines Market by End Use
10.5.6.2 Argentina Nasal Vaccines Market
10.5.6.2.1 Argentina Nasal Vaccines Market by Type
10.5.6.2.2 Argentina Nasal Vaccines Market by Dosage Form
10.5.6.2.3 Argentina Nasal Vaccines Market by End Use
10.5.6.3 Rest of South and Central America Nasal Vaccines Market
10.5.6.3.1 Rest of South and Central America Nasal Vaccines Market by Type
10.5.6.3.2 Rest of South and Central America Nasal Vaccines Market by Dosage Form
10.5.6.3.3 Rest of South and Central America Nasal Vaccines Market by End Use
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL NASAL VACCINES MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. NASAL VACCINES MARKET, KEY COMPANY PROFILES
13.1. SANOFI
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ASTRAZENECA
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. ABBOTT
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. GLAXOSMITHKLINE
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. SERUM INSTITUTE OF INDIA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. BHARAT BIOTECH
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ANTARES PHARMA
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. INJEX PHARMA GMBH
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BIODIEM
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. PHARMAJET
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. Sanofi
2. AstraZeneca
3. Abbott
4. GlaxoSmithKline
5. Serum Institute of India
6. Bharat Biotech
7. Antares Pharma
8. INJEX Pharma GmbH
9. BioDiem
10. PharmaJet
11. Crossject
12. Teva Pharmaceuticals
13. Aptar Pharma
14. UCB, Inc.
15. Teleflex Corporation
16. 3M
17. Bespak
18. OptiNose, Inc.
19. Intersect ENT
TIPRE00023215
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Request for Sample
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.